![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Park-Chung, FS Wu and DH Farb
Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Massachusetts 02118.
We have shown previously that the neurosteroid pregnenolone sulfate acts as a positive allosteric modulator at the N-methyl-D-aspartate (NMDA) receptor while inhibiting the kainate, the alpha-amino-3-hydroxy- 5-methyl-4-isoxazolepropionate (AMPA), the glycine, and the gamma- aminobutyric acid (GABA) responses of chick spinal cord neurons. Here, we report that 3 alpha-hydroxy-5 beta-pregnan-20-one sulfate (5 beta 3 alpha S), a sulfated form of naturally occurring 5 beta 3 alpha, inhibits both the NMDA and the non-NMDA receptor-mediated responses as measured by whole cell voltage clamp recordings. 100 microM 5 beta 3 alpha S rapidly and reversibly inhibits the response to 30 microM NMDA by 66%, 50 microM kainate by 37%, and 25 microM AMPA by 29%. Application of 50 microM nonsulfated 5 beta 3 alpha does not produce any significant effect on the NMDA response, demonstrating that the sulfate moiety is important for the effect of 5 beta 3 alpha S on the NMDA response. The effect of 5 beta 3 alpha S on the NMDA response is concentration dependent, with an EC50 of 62 microM. 5 beta 3 alpha S reduces the maximum NMDA response with little effect on the NMDA EC50, indicating that antagonism of the NMDA response by 5 beta 3 alpha S is noncompetitive. The fact that 5 beta 3 alpha S inhibition of the NMDA response is neither agonist nor voltage dependent demonstrates that 5 beta 3 alpha S does not act as an open channel blocker. Furthermore, inhibition of the NMDA response by 5 beta 3 alpha S is not reduced by the addition of a maximal concentration (10 microM) of glycine, indicating that 5 beta 3 alpha S does not act via the glycine recognition site. The inhibitory action of 5 beta 3 alpha S on the NMDA and non-NMDA receptors may provide a basis for inhibiting glutamate receptor-induced seizures and excitotoxic cell death.
This article has been cited by other articles:
|
|
 |
|
  K. A. Grant, C. M. Helms, L. S. M. Rogers, and R. H. Purdy Neuroactive Steroid Stereospecificity of Ethanol-Like Discriminative Stimulus Effects in Monkeys J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 354 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J Paris and C. A Frye Estrous cycle, pregnancy, and parity enhance performance of rats in object recognition or object placement tasks Reproduction, July 1, 2008; 136(1): 105 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Petrovic, M. Sedlacek, M. Horak, H. Chodounska, and L. Vyklicky Jr 20-Oxo-5{beta}-Pregnan-3{alpha}-yl Sulfate Is a Use-Dependent NMDA Receptor Inhibitor J. Neurosci., September 14, 2005; 25(37): 8439 - 8450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Shannon, P. Porcu, R. H. Purdy, and K. A. Grant Characterization of the Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone in DBA/2J and C57BL/6J Inbred Mice J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 675 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Parizek, M. Hill, R. Kancheva, H. Havlikova, L. Kancheva, J. Cindr, A. Paskova, V. Pouzar, I. Cerny, P. Drbohlav, et al. Neuroactive Pregnanolone Isomers during Pregnancy J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 395 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mennerick, C.-M. Zeng, A. Benz, W. Shen, Y. Izumi, A. S. Evers, D. F. Covey, and C. F. Zorumski Effects on gamma -Aminobutyric Acid (GABA)A Receptors of a Neuroactive Steroid That Negatively Modulates Glutamate Neurotransmission and Augments GABA Neurotransmission Mol. Pharmacol., October 1, 2001; 60(4): 732 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Engel, R. H. Purdy, and K. A. Grant Characterization of Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 489 - 495. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Weaver, M. B. Land, R. H. Purdy, K. G. Richards, T. T. Gibbs, and D. H. Farb Geometry and Charge Determine Pharmacological Effects of Steroids on N-Methyl-D-aspartate Receptor-Induced Ca2+ Accumulation and Cell Death J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 747 - 754. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Bowen, R. H. Purdy, and K. A. Grant Ethanol-Like Discriminative Stimulus Effects of Endogenous Neuroactive Steroids: Effect of Ethanol Training Dose and Dosing Procedure J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 405 - 411. [Abstract] [Full Text]
|
|
|
|
|
|
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis The Glutamate Receptor Ion Channels Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Park-Chung, F.-S. Wu, R. H. Purdy, A. A. Malayev, T. T. Gibbs, and D. H. Farb Distinct Sites for Inverse Modulation of N-Methyl-D-Aspartate Receptors by Sulfated Steroids Mol. Pharmacol., December 1, 1997; 52(6): 1113 - 1123. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. E. Weaver Jr., P. Marek, M. Park-Chung, S. W. Tam, and D. H. Farb Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor PNAS, September 16, 1997; 94(19): 10450 - 10454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Rose, G. Stapleton, K. Dott, M. P. Kieny, R. Best, M. Schwarz, D. W. Russell, I. Bjorkhem, J. Seckl, and R. Lathe Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha -hydroxy dehydroepiandrosterone and 7alpha -hydroxy pregnenolone PNAS, May 13, 1997; 94(10): 4925 - 4930. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
